About Drupal 8
Have you ever felt that your website needs to be more personalized, integrated with cutting-edge technology to offer enhanced user experience?
Valuebound is one of those companies, which specifically help organizations in their path to digital transformation. We enhance digital experience for end users with tailored web applications.
Recent releases
|
Transforming Online Education with Cloud Based Solutions
The growth of technology in ed-tech in the past two years has equaled a decade-long progress. Remote models have led to increasing use of cloud technology in adaptive learning.
|
Road ahead for Drupal 8 contributed projects
Drupal 8 EOL leaves contributed projects in a state where they’re prone to security threats. Therefore they must upgrade to the latest versions.
|
Valuebound’s Journey to Great Place To Work Certification: Interview With Abhijit Upadhyay
Recently accredited with the Great Place to Work® certification, Abhijit Upadhyay, COO of Valuebound shares a decade-long journey of the company in this extensive interview.
|
Product engineer vs. full stack engineer: How are they different?
In the present times of digital transformation, it is no longer important to simply make things workable. The need of the hour is to have a strong technical voice and do the right things for arriving…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
